• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人诱导多能干细胞源性神经元模型中溶酶体水解酶运输和活性分析。

Analysis of lysosomal hydrolase trafficking and activity in human iPSC-derived neuronal models.

机构信息

The Ken and Ruth Davee Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL 60611, USA.

出版信息

STAR Protoc. 2021 Feb 13;2(1):100340. doi: 10.1016/j.xpro.2021.100340. eCollection 2021 Mar 19.

DOI:10.1016/j.xpro.2021.100340
PMID:33659904
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7896187/
Abstract

Lysosomes are critical for maintaining protein homeostasis and cellular metabolism. Lysosomal dysfunction and disrupted protein trafficking contribute to cell death in neurodegenerative disorders, including Parkinson's disease and dementia. We describe three complementary protocols-the use of protein glycosylation, western blotting, immunofluorescence, and hydrolase activity measurement-to analyze the trafficking and activity of lysosomal proteins in patient-derived neurons differentiated from iPSCs. These methods should help to identify lysosomal phenotypes in patient-derived cultures and aid the discovery of therapeutics that augment lysosomal function. For complete details on the use and execution of this protocol, please refer to Cuddy et al. (2019).

摘要

溶酶体对于维持蛋白质内稳态和细胞代谢至关重要。溶酶体功能障碍和蛋白质运输紊乱导致神经退行性疾病(包括帕金森病和痴呆症)中的细胞死亡。我们描述了三种互补的方案——使用蛋白质糖基化、western blot、免疫荧光和水解酶活性测定来分析源自 iPSC 的患者来源神经元中的溶酶体蛋白的运输和活性。这些方法应该有助于鉴定患者来源培养物中的溶酶体表型,并有助于发现增强溶酶体功能的治疗方法。有关该方案使用和执行的完整详细信息,请参阅 Cuddy 等人。(2019 年)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/346d/7896187/a85ee5eb6bf5/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/346d/7896187/a0a3d35d939b/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/346d/7896187/3da70aa1de3b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/346d/7896187/b846cf11df5d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/346d/7896187/1146495c73ca/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/346d/7896187/a85ee5eb6bf5/gr4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/346d/7896187/a0a3d35d939b/fx1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/346d/7896187/3da70aa1de3b/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/346d/7896187/b846cf11df5d/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/346d/7896187/1146495c73ca/gr3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/346d/7896187/a85ee5eb6bf5/gr4.jpg

相似文献

1
Analysis of lysosomal hydrolase trafficking and activity in human iPSC-derived neuronal models.人诱导多能干细胞源性神经元模型中溶酶体水解酶运输和活性分析。
STAR Protoc. 2021 Feb 13;2(1):100340. doi: 10.1016/j.xpro.2021.100340. eCollection 2021 Mar 19.
2
Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.β-葡萄糖脑苷脂酶的激活可减少帕金森病患者中脑神经元的病理性α-突触核蛋白并恢复溶酶体功能。
J Neurosci. 2016 Jul 20;36(29):7693-706. doi: 10.1523/JNEUROSCI.0628-16.2016.
3
iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis.源自 GBA1 相关帕金森病患者的 iPSC 神经元显示自噬缺陷和钙稳态受损。
Nat Commun. 2014 Jun 6;5:4028. doi: 10.1038/ncomms5028.
4
The hexosamine biosynthetic pathway rescues lysosomal dysfunction in Parkinson's disease patient iPSC derived midbrain neurons.己糖胺生物合成途径挽救帕金森病患者 iPSC 衍生中脑细胞溶酶体功能障碍。
Nat Commun. 2024 Jun 19;15(1):5206. doi: 10.1038/s41467-024-49256-3.
5
Neural cells generated from human induced pluripotent stem cells as a model of CNS involvement in mucopolysaccharidosis type II.人诱导多能干细胞分化的神经细胞作为黏多糖贮积症 II 型中枢神经系统受累的模型。
J Inherit Metab Dis. 2018 Mar;41(2):221-229. doi: 10.1007/s10545-017-0108-5. Epub 2017 Nov 22.
6
Protocol to investigate Parkinson's patient-derived dopaminergic neurons by live-cell microscopy and oxidized dopamine assays.通过活细胞显微镜和氧化多巴胺检测来研究帕金森病患者来源的多巴胺能神经元的方案。
STAR Protoc. 2024 Mar 15;5(1):102889. doi: 10.1016/j.xpro.2024.102889. Epub 2024 Feb 10.
7
Detection of pathological alpha-synuclein aggregates in human iPSC-derived neurons and tissue.人诱导多能干细胞源性神经元和组织中病理性 α-突触核蛋白聚集物的检测。
STAR Protoc. 2021 Mar 6;2(1):100372. doi: 10.1016/j.xpro.2021.100372. eCollection 2021 Mar 19.
8
Trehalose induces autophagy via lysosomal-mediated TFEB activation in models of motoneuron degeneration.海藻糖通过溶酶体介导的 TFEB 激活诱导运动神经元退变模型中的自噬。
Autophagy. 2019 Apr;15(4):631-651. doi: 10.1080/15548627.2018.1535292. Epub 2018 Nov 5.
9
Modeling neuronal defects associated with a lysosomal disorder using patient-derived induced pluripotent stem cells.使用患者来源的诱导多能干细胞对与溶酶体相关的神经元缺陷进行建模。
Hum Mol Genet. 2011 Sep 15;20(18):3653-66. doi: 10.1093/hmg/ddr285. Epub 2011 Jun 17.
10
Delineating the Neuropathology of Lysosomal Storage Diseases Using Patient-Derived Induced Pluripotent Stem Cells.利用患者来源的诱导多能干细胞描绘溶酶体贮积症的神经病理学
Stem Cells Dev. 2022 May;31(9-10):221-238. doi: 10.1089/scd.2021.0304. Epub 2022 Apr 27.

引用本文的文献

1
Rab27b Promotes Lysosomal Function and Alpha-Synuclein Clearance in Neurons.Rab27b促进神经元中的溶酶体功能及α-突触核蛋白清除。
J Neurosci. 2025 Apr 2;45(14):e1579242025. doi: 10.1523/JNEUROSCI.1579-24.2025.
2
The hexosamine biosynthetic pathway rescues lysosomal dysfunction in Parkinson's disease patient iPSC derived midbrain neurons.己糖胺生物合成途径挽救帕金森病患者 iPSC 衍生中脑细胞溶酶体功能障碍。
Nat Commun. 2024 Jun 19;15(1):5206. doi: 10.1038/s41467-024-49256-3.
3
A genetically-encoded fluorescence-based reporter to spatiotemporally investigate mannose-6-phosphate pathway.

本文引用的文献

1
Stress-Induced Cellular Clearance Is Mediated by the SNARE Protein ykt6 and Disrupted by α-Synuclein.应激诱导的细胞清除作用是由 SNARE 蛋白 ykt6 介导的,α-突触核蛋白使其受到干扰。
Neuron. 2019 Dec 4;104(5):869-884.e11. doi: 10.1016/j.neuron.2019.09.001. Epub 2019 Oct 21.
2
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease.患者定制型寡核苷酸疗法治疗罕见遗传病。
N Engl J Med. 2019 Oct 24;381(17):1644-1652. doi: 10.1056/NEJMoa1813279. Epub 2019 Oct 9.
3
Modeling neuronopathic storage diseases with patient-derived culture systems.
一种基于基因编码荧光的报告分子,用于时空研究甘露糖-6-磷酸途径。
Mol Biol Cell. 2024 Aug 1;35(8):mr6. doi: 10.1091/mbc.E23-09-0344. Epub 2024 Jun 18.
4
Late-onset Krabbe disease presenting as spastic paraplegia - implications of GCase and CTSB/D.晚发性克拉伯病表现为痉挛性截瘫 - GCase 和 CTSB/D 的影响。
Ann Clin Transl Neurol. 2024 Jul;11(7):1715-1731. doi: 10.1002/acn3.52078. Epub 2024 Jun 4.
5
Development of quantitative high-throughput screening assays to identify, validate, and optimize small-molecule stabilizers of misfolded β-glucocerebrosidase with therapeutic potential for Gaucher disease and Parkinson's disease.开发定量高通量筛选分析方法,以鉴定、验证和优化具有治疗戈谢病和帕金森病潜力的错误折叠β-葡萄糖脑苷脂酶小分子稳定剂。
bioRxiv. 2024 Mar 27:2024.03.22.586364. doi: 10.1101/2024.03.22.586364.
6
Activation and Purification of ß-Glucocerebrosidase by Exploiting its Transporter LIMP-2 - Implications for Novel Treatment Strategies in Gaucher's and Parkinson's Disease.利用其转运蛋白 LIMP-2 激活和纯化β-葡糖脑苷脂酶——对戈谢病和帕金森病新型治疗策略的启示。
Adv Sci (Weinh). 2024 Jul;11(25):e2401641. doi: 10.1002/advs.202401641. Epub 2024 Apr 26.
7
Reciprocal effects of alpha-synuclein aggregation and lysosomal homeostasis in synucleinopathy models.α-突触核蛋白聚集和溶酶体动态平衡在突触核蛋白病模型中的相互影响。
Transl Neurodegener. 2023 Jun 13;12(1):31. doi: 10.1186/s40035-023-00363-z.
8
AAV9/MFSD8 gene therapy is effective in preclinical models of neuronal ceroid lipofuscinosis type 7 disease.腺相关病毒 9/ 溶质载体家族 25 成员 8 基因治疗在神经元蜡样脂褐质沉积症 7 型疾病的临床前模型中是有效的。
J Clin Invest. 2022 Mar 1;132(5). doi: 10.1172/JCI146286.
9
Rescue of α-synuclein aggregation in Parkinson's patient neurons by synergistic enhancement of ER proteostasis and protein trafficking.协同增强内质网蛋白稳态和蛋白质转运以挽救帕金森病患者神经元中的α-突触核蛋白聚集。
Neuron. 2022 Feb 2;110(3):436-451.e11. doi: 10.1016/j.neuron.2021.10.032. Epub 2021 Nov 17.
利用患者来源的培养系统对神经病变性贮积病进行建模。
Neurobiol Dis. 2019 Jul;127:147-162. doi: 10.1016/j.nbd.2019.01.018. Epub 2019 Feb 19.
4
Activation of β-Glucocerebrosidase Reduces Pathological α-Synuclein and Restores Lysosomal Function in Parkinson's Patient Midbrain Neurons.β-葡萄糖脑苷脂酶的激活可减少帕金森病患者中脑神经元的病理性α-突触核蛋白并恢复溶酶体功能。
J Neurosci. 2016 Jul 20;36(29):7693-706. doi: 10.1523/JNEUROSCI.0628-16.2016.
5
α-Synuclein-induced lysosomal dysfunction occurs through disruptions in protein trafficking in human midbrain synucleinopathy models.在人类中脑突触核蛋白病模型中,α-突触核蛋白诱导的溶酶体功能障碍是通过蛋白质运输的破坏而发生的。
Proc Natl Acad Sci U S A. 2016 Feb 16;113(7):1931-6. doi: 10.1073/pnas.1520335113. Epub 2016 Feb 2.
6
Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease.人胚胎干细胞衍生的多巴胺神经元在帕金森病动物模型中有效移植。
Nature. 2011 Nov 6;480(7378):547-51. doi: 10.1038/nature10648.
7
Multiple lysosomal enzyme deficiency due to enzyme leakage?酶泄漏导致多种溶酶体酶缺乏?
N Engl J Med. 1971 Jan 14;284(2):109-10. doi: 10.1056/NEJM197101142840221.